H. Lee Moffitt Cancer Center and Research Institute: Brain Neoplasms trials

The registry lists 12 Brain Neoplasms studies with H. Lee Moffitt Cancer Center and Research Institute as lead sponsor. 1 are open to participants now and 2 have results posted.

Early Phase 1 1Phase 1 8Phase 2 2No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• SRS & Abemaciclib w/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain MetastasesRecruitingNCT04923542Phase 1/2
• Electronic Social Network Assessment Program (eSNAP) + Caregiver NavigatorCompletedNCT04268979Not applicableResults posted
• Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed GlioblastomaCompletedNCT03426891Phase 1Results posted
• Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain MetastasesCompletedNCT05704933Early Phase 1
• Preop fSRS for Resectable Brain MetastasesActive, not recruitingNCT05267587Phase 2
• Stereotactic Radiation and Nivolumab in the Management of Metastatic Breast Cancer Brain MetastasesCompletedNCT03807765Phase 1
• Avelumab With Radiotherapy in Patients With Leptomeningeal DiseaseCompletedNCT03719768Phase 1
• Refining and Testing the Electronic Social Network Assessment Program (eSNAP)CompletedNCT03026699
• Fractionated Stereotactic Radiotherapy (FSRT) in Treatment of Brain MetastasesTerminatedNCT02187822Phase 1
• Metformin in Children With Relapsed or Refractory Solid TumorsCompletedNCT01528046Phase 1
• Study Bendamustine Concurrent Whole Brain Radiation Brain Metastases From Solid TumorsTerminatedNCT00879073Phase 1
• Phase I Study of Temozolomide, Valproic Acid and Radiation Therapy in Patients With Brain MetastasesTerminatedNCT00437957Phase 1